Jump to content

Biopharmaceutics Classification System: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

19 December 2024

2 December 2024

15 December 2023

25 July 2023

23 July 2023

6 September 2022

26 January 2022

13 December 2020

19 October 2020

25 June 2020

6 April 2020

18 December 2019

16 December 2019

3 July 2019

19 February 2019

10 October 2018

10 September 2018

21 February 2017

7 October 2016

3 May 2016

  • curprev 07:2007:20, 3 May 2016 Bembem C. talk contribs 5,337 bytes −25 Assessement of hydrochlorothiazide as BCS class IV is doubtful, see US FDA assessment as BCS class III here: http://www.ncbi.nlm.nih.gov/pubmed/16026005 Dose number is <1up to dose of 25 mg at least undo

9 March 2016

8 March 2016

8 December 2015

9 October 2015

3 October 2015

29 September 2015

5 September 2015

28 August 2015

29 June 2015

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)